Back

Recovery of optimal vitamin D improves responsiveness to phosphodiesterase-5 inhibitors therapy in pulmonary arterial hypertension

13 April 2024 (08:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Hypertension, Pulmonary Hypertension CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Rui Miguel Da Costa Adao

Complutense University of Madrid, Madrid (Spain)

72 More presentations in this session

Presentation thumbnail
Characterization of senescence in human cardiac fibroblasts
Doctor A. Costa (Genoa, IT)
Abstract
Presentation thumbnail
Cardioprotective effect of cemtirestat treatment in male Zucker diabetic fatty rats: a pilot study.
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Dynamic links between the cardiac intermediate filaments of the cytoskeleton and nucleoskeleton for proper cardiomyocyte differentiation, maturation and reprogramming.
Doctor M. Tsikitis (Athens, GR)
Abstract
Presentation thumbnail
Differential sex-dependent role of lncRNAs in cardiomyopathy
Professor D. Franco (Jaen, ES)
Abstract
Presentation thumbnail
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques.
Mr J. Koester (Halle, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Vitamin D as an add-on therapy to phosphodiesterase-5 inhibitor in experimental pulmonary arterial hypertension
19 May 2025
thumbnail
Congress Presentation
Beneficial effects of balloon pulmonary angioplasty on clinical outcomes in patients with residual pulmonary hypertension after pulmonary endarterectomy
28 August 2020
thumbnail
Congress Presentation
Association of vitamin D deficiency and cardiovascular risk factors
20 May 2023
thumbnail
Congress Presentation
Safety and efficacy of sildenafil in patients with advanced heart failure.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources